Pimavanserin is a medication used to treat and manage the hallucinations and delusions associated with Parkinson disease psychosis. It is in the atypical antipsychotic class of drugs. This activity reviews the indication, action, and contraindications for pimavanserin as a valuable agent in managing Parkinson disease psychosis. This activity will highlight the mechanism of action, adverse event profile, dosing, monitoring, relevant interactions, and other key factors pertinent for healthcare team members in the care of patients with Parkinson disease psychosis.

**Objectives:**
- Identify the indications for pimavanserin.
- Review the typical adverse effects of pimavanserin. 
- Summarize the risks associated with initiating pimavanserin, summarizing key patient counseling points.
- Outline the importance of collaboration and coordination among the interprofessional team to enhance patient care when initiating and monitoring pimavanserin to improve patient outcomes for patients receiving treatment for Parkinson disease psychosis.